...
首页> 外文期刊>Planta medica: Natural products and medicinal plant research >In vitro and in vivo antiplasmodial activity of three rwandan medicinal plants and identification of their active compounds
【24h】

In vitro and in vivo antiplasmodial activity of three rwandan medicinal plants and identification of their active compounds

机译:三种卢旺达药用植物的体外和体内抗疟原虫活性及其活性化合物的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

In our previous study, we reported the interesting in vitro antiplasmodial activity of some Rwandan plant extracts. This gave rise to the need for these extracts to also be evaluated in vivo and to identify the compounds responsible for their antiplasmodial activity. The aim of our study was, on the one hand, to evaluate the antiplasmodial activity in vivo and the safety of the selected Rwandan medicinal plants used in the treatment of malaria, with the objective of promoting the development of improved traditional medicines and, on the other hand, to identify the active ingredients in the plants. Plant extracts were selected according to their selectivity index. The in vivo antiplasmodial activity of aqueous, methanolic, and dichloromethane extracts was then evaluated using the classical 4-day suppressive test on Plasmodium berghei infected mice. The activity of the plant extracts was estimated by measuring the percentage of parasitemia reduction, and the survival of the experimental animals was recorded. A bioguided fractionation was performed for the most promising plants, in terms of antiplasmodial activity, in order to isolate active compounds identified by means of spectroscopic and spectrometric methods. The highest level of antiplasmodial activity was observed with the methanolic extract of Fuerstia africana (70%) on days 4 and 7 post-treatment after intraperitoneal injection and on day 7 using oral administration. After oral administration, the level of parasitemia reduction observed on day 4 post-infection was 44% and 37% with the aqueous extract of Terminalia mollis and Zanthoxylum chalybeum, respectively. However, the Z. chalybeum extract presented a high level of toxicity after intraperitoneal injection, with no animals surviving on day 1 post-treatment. F. africana, on the other hand, was safer with 40 % mouse survival on day 20 post-treatment. Ferruginol is already known as the active ingredient in F. Africana, and ellagic acid (IC50=175ng/mL) and nitidine (IC50=77.5ng/mL) were identified as the main active constituents of T. mollis and Z. chalybeum, respectively. F. africana presented very promising antiplasmodial activity in vivo. Although most of the plants tested showed some level of antiplasmodial activity, some of these plants may be toxic. This study revealed for the first time the role of ellagic acid and nitidine as the main antimalarial compounds in T. mollis and Z. chalybeum, respectively.
机译:在我们先前的研究中,我们报道了一些卢旺达植物提取物的有趣的体外抗疟原虫活性。这就需要对这些提取物也进行体内评估,并鉴定出负责其抗血浆活性的化合物。一方面,我们的研究目的是评估体内用于疟疾的抗疟原虫活性以及所选择的用于治疗疟疾的卢旺达药用植物的安全性,目的是促进改良传统药物的开发,以及另一方面,鉴定植物中的活性成分。根据其选择性指数选择植物提取物。然后使用经典的4天抑制试验在伯氏疟原虫感染的小鼠上评估水提取物,甲醇提取物和二氯甲烷提取物的体内抗血浆活性。通过测量寄生虫减少的百分比来估计植物提取物的活性,并记录实验动物的存活。就抗疟原虫活性而言,对最有前途的植物进行了生物引导的分级分离,以分离通过光谱法和光谱法鉴定的活性化合物。在腹腔内注射后第4天和第7天,以及口服给药的第7天,用非洲非洲镰刀菌的甲醇提取物(> 70%)观察到最高的抗血浆活性。口服后,在Terminalia mollis和Zanthoxylum chalybeum的水提物中,感染后第4天观察到的寄生虫减少水平分别为44%和37%。然而,Z.chalybeum提取物在腹膜内注射后表现出高水平的毒性,治疗后第1天没有动物存活。另一方面,非洲扁桃更安全,治疗后20天小鼠存活率为40%。众所周知,非洲草甘蓝醇是有效成分,鞣花酸(IC50 = 175ng / mL)和可尼替丁(IC50 = 77.5ng / mL)分别被鉴定为苜蓿毛囊霉和玉米Z的主要活性成分。 。 F. africana在体内具有非常有希望的抗血浆活性。尽管大多数测试植物显示出一定水平的抗疟原虫活性,但其中一些植物可能是有毒的。这项研究首次揭示了鞣花酸和可尼替丁分别是T. mollis和Z. chalybeum中主要的抗疟化合物的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号